Dr. Elise Ng is as assistant professor of dermatology and the Director of Dermatologic Surgery in the Department of Dermatology at Johns Hopkins. She oversees the Johns Hopkins team of Mohs surgeons across four clinical sites, including the Johns Hopkins Outpatient Center, Greenspring Station, the Medical Pavilion at Howard County, and Sibley Memorial Hospital. She also serves as the Director of the Johns Hopkins Micrographic Surgery and Dermatologic Oncology Fellowship training program and is the clinical co-director of the Melanoma Program at the Sidney Kimmel Comprehensive Cancer Center. Her areas of clinical expertise include Mohs micrographic surgery, complex facial reconstruction following skin cancer surgery, melanoma, cosmetic scar revision, and surgical management of benign and malignant skin lesions. Dr. Ng graduated magna cum laude from Harvard College and was awarded the Harvard College Scholar Award for academic excellence. She received her medical degree from Columbia University College of Physicians and Surgeons and subsequently trained at New York University School of Medicine, one of the nation's top dermatology programs, where she was selected to be chief resident. Following residency, she completed a prestigious fellowship in Mohs micrographic surgery and dermatologic oncology with a focus on advanced reconstruction under the tutelage of one of the leaders in the field at Mount Sinai Hospital in New York. She serves as a reviewer for and her research has been published in premier peer-reviewed journals including Journal of the American Academy of Dermatology and Dermatologic Surgery. Dr. Ng joined the faculty of Johns Hopkins School of Medicine in 2017 and has been consistently recognized as a “Top Doctor” by Baltimore Magazine. Dr. Ng is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Melanoma, and Bowen's Disease.

Deborah Englert is a Dermatologist in Towson, Maryland. Dr. Englert is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Universal Acquired Melanosis, Liver Spots, Neurocutaneous Melanosis, and Familial Atypical Multiple Mole Melanoma Syndrome. Dr. Englert is currently accepting new patients.

Jennifer Cooper is a Dermatologist in Towson, Maryland. Dr. Cooper is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Liver Spots, Universal Acquired Melanosis, Neurocutaneous Melanosis, and Familial Atypical Multiple Mole Melanoma Syndrome. Dr. Cooper is currently accepting new patients.

Zain Syed is a Dermatologist in Lutherville, Maryland. Dr. Syed is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Bowen's Disease, Head and Neck Squamous Cell Carcinoma (HNSCC), and Fasciotomy. Dr. Syed is currently accepting new patients.

Amita Bagal is a Plastic Surgeon and an Otolaryngologist in Lutherville, Maryland. Dr. Bagal is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Ear Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Bagal is currently accepting new patients.

Stanley Miller is a Dermatologist in Towson, Maryland. Dr. Miller is rated as a Distinguished provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Bowen's Disease, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Miller is currently accepting new patients.

Meg Gerstenblith is a clinical associate in dermatology at the Johns Hopkins University School of Medicine, with a focus on general dermatology and melanoma. Dr. Gerstenblith has co-written over 35 peer-reviewed articles and more than 40 abstracts on dermatology and cutaneous oncology. She received her medical degree from the Johns Hopkins University School of Medicine, where she also completed her dermatology residency. Dr. Gerstenblith is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Melanoma, Focal Dermal Hypoplasia, Basal Cell Skin Cancer, and Pigmented Purpuric Dermatosis.

Dr. Ronald Sweren is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous lymphoma/mycosis fungoides, phototherapy/ photopheresis and melanoma. Dr. Sweren also serves as director of the Phototherapy/Photopheresis Program in the Department of Dermatology. Dr. Sweren earned his M.D. from the University of Maryland School of Medicine. He completed his residency in dermatology at University of Maryland Medical Center and in pediatrics at Sinai Hospital of Baltimore. Dr. Sweren is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Mycosis Fungoides, Cutaneous T-Cell Lymphoma (CTCL), Melanoma, and T-Cell Lymphoma.

Dr. William H. Sharfman is an associate professor of oncology and dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include cutaneous oncology, dermatology and immunotherapy. He helped create the well-established Melanoma Program at the Johns Hopkins Kimmel Cancer Center in 1994. Dr. Sharfman serves as the director of cutaneous oncology and clinical co-director for oncology at the Johns Hopkins Melanoma Program. He earned his M.D. from the University of Toledo College of Medicine. He completed his residency at Cleveland Clinic and performed a fellowship in hematology and oncology at Cleveland Clinic. Dr. Sharfman's research interests include novel therapies for high risk and advanced melanoma patients. Dr. Sharfman is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Eccrine Porocarcinoma, and Familial Pancreatic Cancer.

Dr. Joel Sunshine is an Assistant Professor of Dermatology, Pathology, Oncology, and Biomedical Engineering at the Johns Hopkins University School of Medicine. He specializes in medical dermatology and skin cancer. His areas of clinical expertise include general dermatology, cutaneous oncology including melanoma and Merkel cell carcinoma, and supportive oncodermatology. Dr. Sunshine obtained his undergraduate degree from Brandeis University, his M.D. and Ph.D. from Johns Hopkins University School of Medicine, and his dermatology residency training and dermatopathology fellowship from the Northwestern University Feinberg School of Medicine. Dr. Sunshine is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Merkel Cell Carcinoma, Melanoma, Familial Atypical Multiple Mole Melanoma Syndrome, and Hidradenitis Suppurativa.

Connie Qiu is a Dermatologist in Lutherville, Maryland. Dr. Qiu is rated as an Experienced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Pityriasis Lichenoides, Pityriasis Lichenoides Et Varioliformis Acuta, Pityriasis Lichenoides Chronica, and Tieche-Jadassohn Nevus.

Dr. Janis Taube is a professor of dermatology and pathology at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. Her area of clinical expertise is dermatopathology. Dr. Taube serves as the Director of the Division of Dermatopathology and as the Assistant Director of the Dermatoimmunology Laboratory at the School of Medicine. Dr. Taube received her undergraduate degree in engineering from Duke University. She earned her M.D. from Tulane University and her M.Sc. in molecular medicine from University College London. She completed her residency in pathology at Johns Hopkins where she also served as the chief resident, before undertaking a dermatopathology fellowship at Stanford University. In 2009, Dr. Taube returned to Johns Hopkins for her certification in the Melanoma Clinic. She is one of the lead scientific researchers in the Department of Dermatology at Johns Hopkins. She has written over 180 peer-reviewed publications, and her research has been cited over 70,000 times. In addition to running her own research laboratory, she serves as the co-Director of the Mark Foundation Center for Advanced Genomics and Imaging and also as the co-Director of the Tumor Microenvironment Core Laboratory for the Bloomberg~Kimmel Institute for Cancer Immunotherapy. Dr. Taube is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. Her top areas of expertise are Melanoma, Merkel Cell Carcinoma, Basal Cell Skin Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), and Pancreaticoduodenectomy.

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Pancreaticoduodenectomy.

Dr. Jihad Mohamad Alhariri is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include dermatology and medical dermatology. Dr. Alhariri received his undergraduate degree from the American University of Beirut. He earned his M.D. from the American University of Beirut and his M.P.H. from the Johns Hopkins University School of Public Health. He completed a residency in internal medicine at Good Samaritan Hospital of Maryland and a residency in dermatology at Johns Hopkins. Dr. Alhariri is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Melanoma, Hidradenitis Suppurativa, Giant Congenital Melanocytic Nevus, and Giant Congenital Nevus.

Paul Ringelman is a Plastic Surgeon in Baltimore, Maryland. Dr. Ringelman is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Epidural Lipomatosis, Melanoma, Basal Cell Skin Cancer, and Squamous Cell Skin Carcinoma.

Jay Barnett is a Dermatologist in Towson, Maryland. Dr. Barnett is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Giant Congenital Melanocytic Nevus, Familial Atypical Multiple Mole Melanoma Syndrome, Giant Congenital Nevus, and Neurocutaneous Melanosis. Dr. Barnett is currently accepting new patients.

Thomas Yu is a Dermatologist in Towson, Maryland. Dr. Yu is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Liver Spots, Universal Acquired Melanosis, Neurocutaneous Melanosis, and Giant Congenital Melanocytic Nevus. Dr. Yu is currently accepting new patients.

Mark Lowitt is a Dermatologist in Towson, Maryland. Dr. Lowitt is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Sebaceous Adenoma, Syringocystadenoma Papilliferum, Syringoma, and Universal Acquired Melanosis. Dr. Lowitt is currently accepting new patients.

Saif Syed is a Dermatologist in Lutherville, Maryland. Dr. Syed is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Comedones, Kaposiform Hemangioendothelioma, Fetal Cystic Hygroma, and Cerebral Cavernous Malformation. Dr. Syed is currently accepting new patients.

Joel Max is a Dermatologist in Lutherville, Maryland. Dr. Max is rated as an Advanced provider by MediFind in the treatment of Basal Cell Skin Cancer. His top areas of expertise are Actinic Keratosis, Warts, Epidermodysplasia Verruciformis, and Psoriasis. Dr. Max is currently accepting new patients.